[Federal Register Volume 64, Number 170 (Thursday, September 2, 1999)]
[Notices]
[Page 48181]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-22863]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[INFO-99-31]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the CDC Reports
Clearance Officer on (404) 639-7090.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques for other
forms of information technology. Send comments to Seleda Perryman, CDC
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24,
Atlanta, GA 30333. Written comments should be received within 60 days
of this notice.
Proposed Project
Assessment of Exposure to Arsenic through Household Water--New--
National Center for Environmental Health (NCEH). Arsenic is a naturally
occurring element present in food and water as both inorganic and
organic complexes. Epidemiologic evidence shows a strong link between
ingestion of water containing inorganic arsenic and an increase in a
wide variety of cancers (e.g., bladder cancer). Consumption of
contaminated food is the major source of arsenic exposure for the
majority of United States citizens. There are some areas of the United
States where elevated levels of arsenic in water occur with appreciable
frequency. In such areas, ingestion of water can be the dominant source
of arsenic exposure. Currently, the preferred method of treatment of
private, domestic well water containing elevated levels of arsenic is
point-of-use (POU) devices. The acceptability of bottled water and POU
treatment systems as effective means of managing arsenic exposure is
based on the assumption that other water exposures such as bathing,
brushing of teeth, cooking, and occasional water consumption from other
taps contribute relatively minor amounts to a person's total daily
intake of arsenic.
We propose to conduct a study to methodically test the validity of
the commonly-made assumption that secondary exposures such as bathing
will not result in a significant increase in arsenic intake over
background dietary levels. Specifically, we are interested in assessing
urine arsenic levels among individuals where ingestion of arsenic-
containing water is controlled by either POU treatment or use of
bottled water, combined with use of short-term diaries to record diet,
water consumption, and bathing frequency. The total cost to recipients
is $0.00.
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Respondents Number of responses/ response (in Total burden
Respondents respondent hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Recruiting telephone interview.................. 580 1 15/60 145
Survey interview (in person).................... 520 1 30/60 260
Biologic specimen collection.................... 520 1 10/60 88
---------------------------------------------------------------
Total....................................... .............. .............. .............. 493
----------------------------------------------------------------------------------------------------------------
Dated: August 27, 1999.
Nancy Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers
for Disease Control and Prevention (CDC).
[FR Doc. 99-22863 Filed 9-1-99; 8:45 am]
BILLING CODE 4163-18-P
